炎症性肠病中的膳食纤维:我们准备好改变范式了吗?
Dietary Fiber in Inflammatory Bowel Disease: Are We Ready to Change the Paradigm?
作者信息
Loy Laura, Petronio Lorenzo, Marcozzi Giacomo, Bezzio Cristina, Armuzzi Alessandro
机构信息
IBD Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
出版信息
Nutrients. 2024 Apr 10;16(8):1108. doi: 10.3390/nu16081108.
Accumulating evidence from pre-clinical and clinical studies demonstrate the benefit of dietary fibers for inflammatory bowel disease (IBD). However, the majority of patients avoid or limit their consumption to manage their symptoms during the active and remission phases, although limited research supports these long-term dietary habits. Although recent evidence-based dietary guidelines highlight the importance of promoting an adequate intake of dietary fiber in IBD patients, intervention trials have not yet clearly clarified the quality and quantity of dietary fiber that should be consumed to be equally tolerated by and provide benefit for patients with IBD. This narrative review describes dietary fibers and their characteristics, analyzes the real-word studies on the impact of dietary fiber consumption in IBD in different clinical settings, and concludes with potential future directions in fiber research, focusing on the real-world needs of characterizing the consumption of fiber-rich foods and promoting their adequate intake.
临床前和临床研究积累的证据表明膳食纤维对炎症性肠病(IBD)有益。然而,尽管有限的研究支持这些长期饮食习惯,但大多数患者在疾病活动期和缓解期会避免或限制食用膳食纤维以控制症状。尽管最近基于证据的饮食指南强调了促进IBD患者摄入足够膳食纤维的重要性,但干预试验尚未明确阐明IBD患者能够同等耐受并从中获益所需摄入的膳食纤维的质量和数量。本叙述性综述描述了膳食纤维及其特性,分析了在不同临床环境中膳食纤维摄入对IBD影响的真实世界研究,并以纤维研究未来的潜在方向作为结论,重点关注确定富含纤维食物的摄入量并促进其充足摄入的实际需求。